NO20035535L - Gammasekretaseinhibitorer - Google Patents

Gammasekretaseinhibitorer

Info

Publication number
NO20035535L
NO20035535L NO20035535A NO20035535A NO20035535L NO 20035535 L NO20035535 L NO 20035535L NO 20035535 A NO20035535 A NO 20035535A NO 20035535 A NO20035535 A NO 20035535A NO 20035535 L NO20035535 L NO 20035535L
Authority
NO
Norway
Prior art keywords
val
group
leu
alkyl
ile
Prior art date
Application number
NO20035535A
Other languages
English (en)
Other versions
NO329184B1 (no
NO20035535D0 (no
Inventor
Hiroshi Mori
Original Assignee
Hiroshi Mori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hiroshi Mori filed Critical Hiroshi Mori
Publication of NO20035535D0 publication Critical patent/NO20035535D0/no
Publication of NO20035535L publication Critical patent/NO20035535L/no
Publication of NO329184B1 publication Critical patent/NO329184B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20035535A 2002-04-24 2003-12-11 Gammasekretaseinhibitorer og anvendelse av disse i screening av inhibitorer av amyloidproteinproduksjon NO329184B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002121983 2002-04-24
PCT/JP2003/005017 WO2003091278A1 (fr) 2002-04-24 2003-04-18 Inhibiteurs de gamma secretase

Publications (3)

Publication Number Publication Date
NO20035535D0 NO20035535D0 (no) 2003-12-11
NO20035535L true NO20035535L (no) 2004-02-19
NO329184B1 NO329184B1 (no) 2010-09-06

Family

ID=29267426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035535A NO329184B1 (no) 2002-04-24 2003-12-11 Gammasekretaseinhibitorer og anvendelse av disse i screening av inhibitorer av amyloidproteinproduksjon

Country Status (11)

Country Link
US (1) US7585938B2 (no)
EP (1) EP1498421B1 (no)
JP (1) JP4404643B2 (no)
KR (1) KR101051249B1 (no)
CN (1) CN1319987C (no)
AT (1) ATE448242T1 (no)
AU (1) AU2003235283A1 (no)
BR (1) BR0304562A (no)
DE (1) DE60329995D1 (no)
NO (1) NO329184B1 (no)
WO (1) WO2003091278A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US8173423B2 (en) * 2006-11-07 2012-05-08 Vib Vzw Diagnosis and treatment of T-cell acute lymphoblastic leukemia
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
DK2142514T3 (da) 2007-04-18 2015-03-23 Probiodrug Ag Thioureaderivater som glutaminylcyclase-inhibitorer
US8501813B2 (en) 2007-08-09 2013-08-06 Kabushiki Kaisha Yakult Honsha γ-secretase inhibitor
EA022007B1 (ru) 2009-09-11 2015-10-30 Пробиодруг Аг Гетероциклические производные в качестве ингибиторов глутаминилциклазы
WO2012144972A2 (en) * 2010-01-19 2012-10-26 The General Hospital Corporation Methods to inhibit neurodegeneration
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
BR112012022478B1 (pt) 2010-03-10 2021-09-21 Probiodrug Ag Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
CN102344485A (zh) * 2010-08-05 2012-02-08 中国人民解放军军事医学科学院毒物药物研究所 用于治疗阿尔茨海默病的肽类β分泌酶抑制剂及其用途
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
WO2016059220A1 (en) 2014-10-16 2016-04-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Tcr-activating agents for use in the treatment of t-all
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI870474A (fi) * 1986-02-07 1987-08-08 Ciba Geigy Ag Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat.
JP2003520266A (ja) 2000-01-24 2003-07-02 メルク シャープ エンド ドーム リミテッド γ−セクレターゼ阻害薬
US6753410B2 (en) * 2000-03-02 2004-06-22 Merck & Co., Inc. Investigational compounds
WO2001085924A2 (en) * 2000-05-11 2001-11-15 Scios Inc. MODULATION OF η-SECRETASE ACTIVITY
US20030022251A1 (en) * 2001-07-04 2003-01-30 Boehringer Ingelheim Pharma Kg Gamma-secretase in vitro screening assay

Also Published As

Publication number Publication date
DE60329995D1 (de) 2009-12-24
EP1498421B1 (en) 2009-11-11
ATE448242T1 (de) 2009-11-15
EP1498421A1 (en) 2005-01-19
KR20040106370A (ko) 2004-12-17
NO329184B1 (no) 2010-09-06
NO20035535D0 (no) 2003-12-11
JP4404643B2 (ja) 2010-01-27
CN1656115A (zh) 2005-08-17
AU2003235283A1 (en) 2003-11-10
US20060205666A1 (en) 2006-09-14
BR0304562A (pt) 2004-07-20
EP1498421A4 (en) 2006-05-17
US7585938B2 (en) 2009-09-08
CN1319987C (zh) 2007-06-06
JPWO2003091278A1 (ja) 2005-09-02
KR101051249B1 (ko) 2011-07-21
WO2003091278A1 (fr) 2003-11-06

Similar Documents

Publication Publication Date Title
NO20035535D0 (no) Gammasekretaseinhibitorer
BR0114147A (pt) Uso de tensoativos catiÈnicos em preparações cosméticas
PE107299A1 (es) Composiciones farmaceuticas que comprenden un analogo de gaba y un antiinflamatorio no esteroideo
SE9203825D0 (sv) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
AU2002333155A1 (en) Dermopharmaceutically and cosmetically active oligopeptides
ES2421447T3 (es) Métodos para proteger frente a apoptosis usando lipopéptidos
WO2005115113A3 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
MX9705559A (es) Derivados de acido neuraminico, su preparacion y su uso en medicina.
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
CY1107990T1 (el) Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων
BR0315864A (pt) Composições e processos para a modificação efeitos tóxicos de compostos proteináceos
PT1226160E (pt) Novos peptidos antiarritmicos
DK0624586T3 (da) Substituerede pyrroler
BR0208999A (pt) Processo para a preparação de ácido de cefpodoxima
DE59900730D1 (de) Korrosionsinhibitoren enthaltender Injektionszement
EP2279741A3 (en) Caprolactams and their use as anti-inflammatory agents
IL153830A0 (en) A PROCESS FOR THE PREPARATION OF alpha' CHLOROKETONES
ITMI20030063A1 (it) Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
HRP20050242B1 (en) Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
WO2003018795A1 (fr) Nouveau peptide rfrp-3 et adn de celui-ci
UA102215C2 (ru) Отверждающие агенты для эпоксифункциональных соединений
DK0737691T3 (da) Bombesinanaloger
AU2002364471A1 (en) Use of methyl glycine diacetic acid or the derivatives thereof as an exfoliant
BR0213199A (pt) Compostos de poliepóxi tendo uma ligação de amida
WO2004065411A3 (en) Peptides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees